TY - JOUR
T1 - Expression and activation of the reprogramming transcription factors
AU - Guo, Jun
AU - Li, Zi cheng
AU - Feng, Ying hong
PY - 2009/12/25
Y1 - 2009/12/25
N2 - Recently, a series of exciting reports have revealed that terminally differentiated somatic cells can be reprogrammed to generate induced pluripotent stem (iPS) cells via overexpression of a cocktail of transcription factors such as Oct3, Sox2, Klf4, and c-Myc or Oct3, Sox2, Nanog, and Lin28. Most recently, these iPS cells has been used to generate viable, live-born progeny by tetraploid complementation. Reprogramming of iPS cells inaugurates a new era of biology and medicine, it inevitably brings new challenges, e.g., how these factors induce reprogramming and how their expression is regulated. To facilitate iPS cell research, this review focuses on how expression and activation of these transcription factors are regulated.
AB - Recently, a series of exciting reports have revealed that terminally differentiated somatic cells can be reprogrammed to generate induced pluripotent stem (iPS) cells via overexpression of a cocktail of transcription factors such as Oct3, Sox2, Klf4, and c-Myc or Oct3, Sox2, Nanog, and Lin28. Most recently, these iPS cells has been used to generate viable, live-born progeny by tetraploid complementation. Reprogramming of iPS cells inaugurates a new era of biology and medicine, it inevitably brings new challenges, e.g., how these factors induce reprogramming and how their expression is regulated. To facilitate iPS cell research, this review focuses on how expression and activation of these transcription factors are regulated.
KW - Expression
KW - Reprogramming
UR - http://www.scopus.com/inward/record.url?scp=70450280575&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2009.11.017
DO - 10.1016/j.bbrc.2009.11.017
M3 - Short survey
C2 - 19900408
AN - SCOPUS:70450280575
SN - 0006-291X
VL - 390
SP - 1081
EP - 1086
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 4
ER -